Elevance Health (ELV) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.

ELV eyes a Medicaid margin recovery in 2027 as reimbursement rates improve, but elevated medical costs and uneven state adjustments remain key hurdles.…

Elevance Health (NYSE: ELV - Get Free Report) and Alignment Healthcare (NASDAQ: ALHC - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the s…

Aberdeen Group plc grew its stake in Elevance Health, Inc. (NYSE: ELV) by 6.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 298,585 shares …

Elevance Health NYSE: ELV expects adjusted earnings per share to grow at least 12% in 2027 from its recently increased 2026 baseline of at least $26.75, Chief Financial Officer Mark Kaye said at a UBS conference.…

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned indicative Long-Term Issue Credit Ratings of “bbb+” (Good) to senior unsecured issues, “bbb” (Good) to subordinated issues and “bbb-” (Good) to preferred …

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Revvity (RVTY). But which of these two companies is the best option for those looking for undervalued stocks?…

Wall Street is punishing CVS Health (NYSE:CVS | CVS Price Prediction) for a plan to break up the pharmacy, benefits and insurance empire it spent years building, even after a strong quarter. CVS stock is at $80.…

Does Elevance Health (ELV) have what it takes to be a top stock pick for momentum investors? Let's find out.…

On October 27, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown notable price performance over the past year, with a…

Citizens Financial Group Inc. RI increased its position in shares of Elevance Health, Inc. (NYSE: ELV) by 77.0% in a recent quarter, according to the company in its most recent 13F filing with the Securities and Exchange…

Investors need to pay close attention to ELV stock based on the movements in the options market lately.…

Iridian Asset Management LLC CT decreased its holdings in Elevance Health, Inc. (NYSE: ELV) by 31.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fir…

Elevance Health, Inc. (NYSE: ELV - Get Free Report) CFO Mark Kaye sold 10,584 shares of the stock in a transaction that occurred on Thursday, October 22nd. The stock was sold at an average price of $440.13, for a total v…

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or Revvity (RVTY). But which of these two stocks offers value investors a better bang for their buck right n…

Elevance Health raised its 2026 adjusted EPS guidance to at least $29, but the sustainability of its earnings recovery remains uncertain. Third-quarter adjusted EPS rose 15.9%, while nine-month operating gain declined 25…

Elevance raised its 2026 earnings baseline to at least $26.75 per share. Carelon's cancer program reduced avoidable inpatient admissions by 15%.…

Intuitive Surgical (ISRG) and Elevance Health (ELV) delivered impressive Q3 earnings beats, making both healthcare stocks worth considering as their growth outlooks improve.…

Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.…

Elevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript…

Elevance Health beats Q3 EPS estimate by 50% as Carelon grows despite declining medical membership, and lifts its 2026 underlying earnings baseline to $26.75.…

Elevance Health NYSE: ELV raised its 2026 earnings outlook after reporting third-quarter adjusted diluted earnings per share of $6.99, exceeding the company's expectations as Medicaid, Medicare Advantage and Individual A…

While the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall St…

Elevance Health (ELV) came out with quarterly earnings of $6.99 per share, beating the Zacks Consensus Estimate of $4.66 per share. This compares to earnings of $6.03 per share a year ago.…

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) today announced the appointment of Jeff Park as President of Carelon, effective December 1, 2026. In this role, Park will lead Carelon through its next phase of …

For the third quarter, the health-insurance company reported a rise in net income to $1.34 billion, or $6.27 a share, compared with $1.19 billion, or $5.32 a share, a year earlier.…

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported third quarter 2026 results ahead of expectations. "Elevance Health's third quarter results reflect stronger execution across our diversified portf…

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through m…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Jan 26. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.
Quiet tape today.

